Irinotecan and temozolomide upfront and in relapsed Ewing sarcoma: A translational study on MGMT (O6-methylguanine-DNA methyltransferase) and ABCG2 (MGMTLiberati).

被引：0
|
作者：
Palmerini, Emanuela
Pasello, Michela
Jones, Robin Lewis
Manara, Maria Cristina
Fagioli, Franca
Grignani, Giovanni
Longhi, Alessandra
Cesari, Marilena
Abate, Massimo Eraldo
Paioli, Anna
Setola, Elisabetta
Hakim, Rossella
D'Ambrosio, Lorenzo
Parra, Alessandro
Sebastian, Asaftei Dorin
Righi, Alberto
Morandi, Luca
Donati, Davide Maria
Ferrari, Stefano
Scotlandi, Katia
机构：
[1] IRCCS, Ist Ortoped Rizzoli, Bologna, Italy
[2] Royal Marsden Hosp, Inst Canc Res, London, England
[3] Univ Turin, AOU Citta Salute & Sci, Pediat Oncohematol, Turin, Italy
[4] FPO IRCCS, Div Med Oncol, Candiolo Canc Inst, Candiolo, TO, Italy
[5] IRCCS, Chemotherapy Unit, Ist Ortoped Rizzoli, Bologna, Italy
[6] Santobono Pausilipon Childrens Hosp, Dept Pediat Oncol, Naples, Italy
[7] Univ Bologna, Dept Biomed & Neuromotor Sci, Funct MR Unit, IRCCS,Ist Sci Neurol, Bologna, Italy
[8] IRCCS, Orthoped Clin & Traumatol 3, Ist Ortoped Rizzoli, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23564
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The MGMT (O6-methylguanine-DNA methyltransferase) promotes methylation and clinical outcomes of salvage temozolomide and irinotecan chemotherapy in progressive Ewing sarcoma: A preliminary report.
    Salah, Samer
    Naser, Walid
    Jaber, Omar
    Saleh, Yacob
    Mustafa, Rawan Mohammed Mahmoud
    Abuhijlih, Ramiz
    Abuhijla, Fawzi
    Yaser, Sameer
    Sultan, Iyad Yasin
    Mustafa, Nour
    Tbakhi, Abdelghani
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Does MGMT (O6-methylguanine-DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)?
    Palmerini, Emanuela
    Pasello, Michela
    Jones, Robin Lewis
    Manara, Maria Cristina
    Parra, Alessandro
    Picci, Piero
    Grignani, Giovanni
    Marchesi, Emanuela
    Cesari, Marilena
    Longhi, Alessandra
    Abate, Massimo
    Paioli, Anna
    D'Ambrosio, Lorenzo
    Fagioli, Franca
    Dorin, Asaftei Sebastian
    Ferrari, Stefano
    Scotlandi, Katia
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma
    Xiaoyin Jiang
    David A. Reardon
    Annick Desjardins
    James J. Vredenburgh
    Jennifer A. Quinn
    Alan D. Austin
    James E. Herndon
    Roger E. McLendon
    Henry S. Friedman
    Journal of Neuro-Oncology, 2013, 114 : 135 - 140
  • [4] O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma
    Jiang, Xiaoyin
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Quinn, Jennifer A.
    Austin, Alan D.
    Herndon, James E., II
    McLendon, Roger E.
    Friedman, Henry S.
    JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) : 135 - 140
  • [5] Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
    McCormack, Ann I.
    McDonald, Kerrie L.
    Gill, Anthony J.
    Clark, Susan J.
    Burt, Morton G.
    Campbell, Kirsten A.
    Braund, Wilton J.
    Little, Nicholas S.
    Cook, Raymond J.
    Grossman, Ashley B.
    Robinson, Bruce G.
    Clifton-Bligh, Roderick J.
    CLINICAL ENDOCRINOLOGY, 2009, 71 (02) : 226 - 233
  • [6] O6-methylguanine-DNA methyltransferase (MGMT) Promoter methylation is a rare event in soft tissue sarcoma
    Jens Jakob
    Maren Hille
    Christian Sauer
    Philipp Ströbel
    Frederik Wenz
    Peter Hohenberger
    Radiation Oncology, 7
  • [7] O6-methylguanine-DNA methyltransferase (MGMT) Promoter methylation is a rare event in soft tissue sarcoma
    Jakob, Jens
    Hille, Maren
    Sauer, Christian
    Stroebel, Philipp
    Wenz, Frederik
    Hohenberger, Peter
    RADIATION ONCOLOGY, 2012, 7
  • [8] O6-Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?
    Hiddinga, Birgitta I.
    Pauwels, Patrick
    Janssens, Annelies
    van Meerbeeck, Jan P.
    LUNG CANCER, 2017, 107 : 91 - 99
  • [9] Towards more specific O6-methylguanine-DNA methyltransferase (MGMT) inactivators
    Lopez, Sergio
    Margison, Geoffrey P.
    McElhinney, R. Stanley
    Cordeiro, Alessandra
    McMurry, T. Brian H.
    Rozas, Isabel
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (05) : 1658 - 1665
  • [10] O6-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives
    Okamoto, R
    Takano, H
    Okamura, T
    Park, JS
    Tanimoto, K
    Sekikawa, T
    Yamamoto, W
    Sparreboom, A
    Verweij, J
    Nishiyama, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (01): : 93 - 102
12345